Phosphate transport: from microperfusion to molecular cloning
- 268 Downloads
Inorganic phosphate (Pi) is a constituent of important biological molecules (e.g., nucleic acids and phospholipids) and is essential for cellular energetics and signaling, and protein synthesis as well as skeletal development in all mammalian organisms. Inadequate Pi supply causes bone malformations such as rickets and spinal deformations, whereas an excess in Pi is linked to vascular calcification or ectopic CaPi deposits. In general, whole-body Pi homeostasis is maintained by transepithelial transport mechanisms in the small intestine and kidney where Pi is absorbed from the diet and reabsorbed from the glomerular filtrate, respectively. The renal proximal tubule is the main locus of Pi regulation so that under “steady-state” physiological conditions, renal Pi-excretion corresponds approximately to dietary Pi intake.
Membrane transport proteins belonging to the SLC34 solute carrier family1 lie at the heart of maintaining Pi homeostasis. In the small intestine, NaPi-IIb (SLC34A2) mediates luminal Pi uptake together with a paracellular component, whereas the renal isoforms NaPi-IIa (SLC34A1) and NaPi-IIc (SLC34A3) are responsible for Pi reabsorption in the proximal tubule. This Special Issue focusing on phosphate transport mediated by SLC34 proteins was conceived to coincide with an important milestone in renal physiology: the expression cloning of the first member of the SLC34 family (NaPi-IIa) just over a quarter of a century ago . This, together with the subsequent identification of the other two SLC34 isoforms [24, 42], has paved the way for a deeper understanding of the molecular basis of Pi homeostasis, many aspects of which are the subject of dedicated reviews in this issue. Whereas the pivotal role of SLC34 cotransporters in maintaining Pi homeostasis is undisputed, other carriers such as PIT-1 and PIT-2 (SLC20 family) may also contribute to epithelial transport of Pi in the intestine and the kidney. However, their respective contributions to overall Pi balance remain to be clarified and will not be the main focus of the present Special Issue.
Following the cloning of NaPi-IIa , the phosphate physiology field has progressed rapidly, benefitting from advances in molecular and cell biology, imaging, and biophysical assays, as exemplified by the invited articles. Therefore, it is easy to overlook how key aspects of our present knowledge of Pi handling had already been established prior to 1993. A brief reflection on the main findings of these earlier studies seems appropriate to set the scene for the developments that have taken place over the past 25 years.
The molecular identity of the proteins involved in Pi transport was a pressing question and attempts were undertaken to identify the transporter by biochemical means in the pre-cloning era. For example, given that PTH affects renal Pi reabsorption and Na+/Pi-cotransport in BBMVs in a cAMP-dependent manner, phosphorylation studies were performed with isolated BBMVs. These studies demonstrated cAMP-dependent changes of BBMV protein-phosphorylation, but the identity of those phospho-proteins remained unknown .
The cloning of NaPi-IIa [32, 33] heralded a new era in the field by enabling the study of the transport mechanisms/characteristics in isolation after injection of cRNA into oocytes of Xenopus laevis . By knowing the amino acid sequence, specific antibodies could be raised to enable specific in situ protein detection of each isoform. Studies using these antibodies allowed the detailed characterization of the cellular mechanisms that are involved in the physiological regulation by an increasing number of hormones. It was also possible to answer questions regarding the interaction with other proteins that are involved in the cellular regulation of Na+/Pi-cotransport.
The collection of invited reviews in this Special Issue gives a comprehensive summary of the impressive progress that has been made in the Pi field since the early cloning days. It is our hope that these articles will provide a useful overview for experts and non-experts alike and stimulate continued research in the Pi field. The reviews have been grouped according to five themes: Molecular and Mechanistic Aspects, including interacting proteins [12, 13, 23, 43], Physiological Regulation [26, 27, 48], Human Mutations/Clinical Aspects and Diseases [4, 30], Non-renal Roles for SLC34 Proteins [3, 34], and Comparative Aspects [39, 52].
Historically, the nomenclature of the cloned, mammalian Pi transporters followed a strictly chronological convention, beginning with the type 1 (NaPi-I) [10, 53] (since shown to be related to an anion conductance and not directly mediate Na-dependent Pi transport ); the type II (NaPi-II  or npt2) and the type III (NaPi-III [28, 29], or Pit-1,2). The widely used solute carrier (SLC) nomenclature  assigns the type I transporters to the SLC17 gene family; type II Na-Pi transporters to SLC34 and type III transporters to SLC20, respectively. The SLC system is increasingly used, i.e., SLC34A1, SLC34A2, and SLC34A3 for the human type II transporters NaPi-IIa, NaPi-IIb, and NaPi-IIc, respectively. The structurally similar isoforms are grouped into the same sub-family (SLC34A) with individual indices (1, 2, 3). This nomenclature is easily applicable to most vertebrates; it only becomes less clear in the case of fish that have undergone genome duplications followed by lineage specific gene losses.
- 1.Ansermet C, Moor MB, Centeno G, Auberson M, Hu DZ, Baron R, Nikolaeva S, Haenzi B, Katanaeva N, Gautschi I, Katanaev V, Rotman S, Koesters R, Schild L, Pradervand S, Bonny O, Firsov D (2016) Renal Fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2016070726
- 3.Beck L (2018) Expression and function of Slc34 sodium–phosphate co-transporters in skeleton and teeth. Pflugers Arch. https://doi.org/10.1007/s00424-018-2240-y
- 4.Bergwitz C, Miyamoto KI (2018) Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy. Pflugers Arch. https://doi.org/10.1007/s00424-018-2184-2
- 10.Busch AE, Schuster A, Waldegger S, Wagner CA, Zempel G, Broer S, Biber J, Murer H, Lang F (1996) Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc Natl Acad Sci U S A 93:5347–5351CrossRefGoogle Scholar
- 12.Fenollar-Ferrer C, Forrest LR (2018) Structural models of the NaPi-II sodium-phosphate cotransporters. Pflugers Arch. https://doi.org/10.1007/s00424-018-2197-x
- 13.Forster IC (2018) The molecular mechanism of SLC34 proteins: insights from two decades of transport assays and structure-function studies. Pflugers Arch. https://doi.org/10.1007/s00424-018-2207-z
- 14.Forster IC, Loo DD, Eskandari S (1999) Stoichiometry and Na+ binding cooperativity of rat and flounder renal type II Na+-Pi cotransporters. Am J Physiol 276:F644–F649Google Scholar
- 15.Fromter E (1979) The Feldberg Lecture 1976. Solute transport across epithelia: what can we learn from micropuncture studies in kidney tubules? J Physiol 288:1–31Google Scholar
- 23.Hernando N (2018) NaPi-IIa interacting partners and their (un)known functional roles. Pflugers Arch. https://doi.org/10.1007/s00424-018-2176-2
- 26.Hu MC, Shi M, Moe OW (2018) Role of aKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters. Pflugers Arch. https://doi.org/10.1007/s00424-018-2238-5
- 27.Jacquillet G, Unwin RJ (2018) Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflugers Arch. https://doi.org/10.1007/s00424-018-2231-z
- 30.Lederer E, Wagner CA (2018) Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease assocations. Pflugers Arch. https://doi.org/10.1007/s00424-018-2246-5
- 32.Magagnin S, Werner A (2018) Expression cloning human and rat renal cortex Na/Pi cotransporters: behind the scenes in the Murer laboratory. Pflugers Arch. https://doi.org/10.1007/s00424-018-2198-9
- 34.Marks J (2018) The role of SLC34A2 in intestinal phosphate absorption and phosphate homeostasis. Pflugers Arch. https://doi.org/10.1007/s00424-018-2221-1
- 36.Murer H, Evers C, Stoll R, Kinne R (1977) The effect of parathyroid hormone (PTH) and dietary phosphate on the sodium-dependent phosphate transport system located in the rat renal brush border membrane. Curr Probl Clin Biochem 8:455–462Google Scholar
- 39.Muscher-Banse AS, Breves G (2018) Mechanisms and regulation of epithelial phosphate transport in ruminants: approaches in comparative physiology. Pflugers Arch. https://doi.org/10.1007/s00424-018-2181-5
- 41.Sacktor B, Cheng L (1981) Sodium gradient-dependent phosphate transport in renal brush border membrane vesicles. Effect of an intravesicular greater than extravesicular proton gradient. J Biol Chem 256:8080–8084Google Scholar
- 43.Sorribas V, Guillén N, Sosa C (2018) Substrates and inhibitors of phosphate transporters: from experimental tools to pathophysiological relevance. Pflugers Arch. https://doi.org/10.1007/s00424-018-2241-x
- 47.Szczepanska-Konkel M, Yusufi AN, VanScoy M, Webster SK, Dousa TP (1986) Phosphonocarboxylic acids as specific inhibitors of Na+-dependent transport of phosphate across renal brush border membrane. J Biol Chem 261:6375–6383Google Scholar
- 48.Tatsumi S, Katai K, Kaneko I, Segawa H, Miyamoto KI (2018) NAD metabolism and the SLC34 family: evidence for a liver-kidney axis regulating inorganic phosphate. Pflugers Arch. https://doi.org/10.1007/s00424-018-2204-2
- 49.Ullrich KJ, Frömter E, Baumann K (1970) Micropuncture and microanalysis in kidney physiology. In: Passow H, Stämpfli R (eds) Laboratory techniques in membrane biophysics. Springer, Heidelberg, pp 106–129Google Scholar
- 52.Verri T, Werner A (2018) Type II Na+-phosphate cotransporters and phosphate balance in teleost fish. Pflugers Arch. https://doi.org/10.1007/s00424-018-2239-4